Maddy Kennedy is an accomplished finance professional with extensive experience in strategic development, financial modeling, and funding within the life sciences sector. Currently serving as Director at CFO4Growth, Maddy has a strong track record in CFO roles across various organizations, including interim positions at PBD Biotech, MAXWELLIA, Kesmalea Therapeutics, and Ieso Digital Health. As a Non-Executive Director at Nuformix Plc and Tetris Pharma Limited, Maddy has contributed to corporate governance and financial oversight. Maddy's educational background includes a Post Graduate Diploma in Financial Strategy from Saïd Business School, University of Oxford, and certifications in Corporate Finance and Accounting from respected institutions. Key competencies encompass mentoring finance teams, guiding companies through mergers and acquisitions, and implementing robust financial frameworks.
January, 2024 - present